Abstract: Previous studies had identified novel antimicrobial peptides derived from witch flounder. In this work, we extended the search for the activity of peptide that showed antibacterial activity on clinically isolated bacterial cells and bacterial biofilm. Pseudomonas aeruginosa was obtained from otitis media and cholelithiasis patients, while Staphylococcus aureus was isolated from otitis media patients. We found that synthetic peptide NRC-16 displays antimicrobial activity and is not sensitive to salt during its bactericidal activity. Interestingly, this peptide also led to significant inhibition of biofilm formation at a concentration of 4-16 μM. NRC-16 peptide is able to block biofilm formation at concentrations just above its minimum inhibitory concentration while conventional antibiotics did not inhibit the biofilm formation except ciprofloxacin and piperacillin. It did not cause significant lysis of human RBC, and is not cytotoxic to HaCaT cells and RAW264.7 cells, thereby indicating its selective antimicrobial activity. In addition, the peptide's binding and permeation activities were assessed by tryptophan fluorescence, calcein leakage and circular dichroism using model mammalian membranes composed of phosphatidylcholine (PC), PC/cholesterol (CH) and PC/sphingomyelin (SM). These
patients in whom otitis media and biofilm inhibition were observed. We synthesized NRC-16 peptide that showed antimicrobial activity and inhibited biofilm formation with no cytotoxic effects. 
Results and Discussion

Lytic Effects of NRC-16
Development of new types of antibiotic compounds is an exciting area of research. Numerous studies have demonstrated that AMPs can be the next line of compounds to overcome bacterial resistance [12, 22] . AMPs are now one of the most promising candidates against MDR bacterial strains. For these reasons, we assessed the antimicrobial activity of NRC-16 using 96-well plate as an indication of in vitro assays that were used to measure the antimicrobial activity of NRC-16 against three strains of Gram-negative bacteria, two strains of Gram-positive bacteria and fungal cells, and 32 strains of antibiotic-resistant bacteria including P. aeruginosa and S. aureus. We also tested the effects of one of the AMPs, melittin, which acted as a control peptide. As shown in Table 1 , the minimum inhibitory concentrations (MICs) of NRC-16 ranged from 2 to 16 μM in low (sodium phosphate (SP) buffer) and high ionic strength buffer (phosphate-buffered saline (PBS)) against nearly all standard strains of bacteria and fungal cells. The antimicrobial activity of the two peptides was slightly inhibited in the presence of PBS (Table 1) . NRC-16 also exerts potent antimicrobial activity against a wide variety of drug-resistant E. coli, S. typhimurium and S. aureus (Table 1 ). The MDR P. aeruginosa and S. aureus strains were of critical concern among the strains tested ( Table 2 ). The results indicated that the peptide was very effective against both P. aeruginosa and S. aureus strains. The order of activity of NRC-16 is similar to that of fish peptides such as pleurocidin and piscidins, showing a good activity against MDR, and thus opening up the possibility of identification and isolation of other peptides from fish or marine organisms [23, 24] . We show here that NRC-16 notably exerted both antibacterial and antifungal activity against antibiotic-resistant strains like piscidin and pleurocidin [24] , which may decrease the chance of candidal superinfections normally associated with bacterial infection on skin such as in atopic dermatitis [25] .
Antimicrobial assays were performed in 10 mM SP buffer, pH 7.2 and PBS, pH 7.2 (number in parentheses in the Table 1 represents MICs of NRC-16 in PBS against standard strains of bacteria and fungal cells). To determine the bactericidal action of NRC-16 in the presence of salt, NaCl is added in Mueller Hinton broth (MHB) up to a concentration of 200 mM. NaCl did not affect the bactericidal activity of NRC-16 against P. aeruginosa 1034 and 4007 (data not shown), indicating that NaCl ions were not inhibiting the peptide's bactericidal action, unlike salt-sensitive activities of several peptides including beta defensin [28, 29] , magainin [30] and LL-37 [31] . However, not all AMPs are salt sensitive, and some peptides show potent salt-insensitive antimicrobial activities (e.g., clavanin, and tachyplesins) [30, 32] . NRC-16's action is also consistent with other fish peptide pleurocidin, which is not sensitive to salt conditions such as NaCl, MgCl 2 and CaCl 2 [23] . 
Effect of AMPs on the P. aeruginosa Biofilm
In addition to ear infections, and lung infections in cystic fibrosis patients, caused by P. aeruginosa [9, 33] , it is an environmental organism that regularly causes both acute and chronic infections and is one of the leading causes of morbidity and mortality in thermally injured patients [34] [35] [36] . Moreover, P. aeruginosa is capable of causing biofilm infection in a wound [37, 38] . It is likely that a wound environment is able to support the development of bacterial biofilms because when thermal injury damages the skin, which paves the way for bacteria, the host's immune system becomes suppressed. Within the wound, MDR bacteria often develop biofilms that could have a significant effect on inflammation, infection and healing [39] . Interestingly, it has been shown that P. aeruginosa formed a biofilm in the thermal mouse model of acute infections [40] . We cultured the P. aeruginosa in 96 wells, allowing the formation of biofilm by the production of an extracellular matrix of various polysaccharides, macromolecules and the up-regulation of a number of genes involved in surface attachment [41, 42] . We then applied antimicrobial agents to evaluate their inhibitory effect on the biofilm growth. This study revealed that P. aeruginosa strains isolated from otitis media were highly resistant to important antibiotics (ampicillin, chlorophenical, erythromycin, levofloxacin and ciprofloxacin) (Table 3) , as no inhibition was observed. The resistance of MDR P. aeruginosa strains to ciprofloxacin is consistent with the previous report [43] . However, pipracillin at a higher concentration showed biofilm inhibition activity, which, in agreement with previous studies results, indicated that high concentrations of antibiotics are needed to drive the antibiofilm activity [44, 45] . Bacteria forming biofilms may be up to 1000 times more resistant to antimicrobial agents than those in a planktonic state [46] . Remarkably, NRC-16 and melittin peptides showed elevated inhibitory effect on all the strains of P. aeruginosa isolated from patients with otitis media (Table 2) , with a minimum biofilm inhibition concentration (MBIC) in the range of 4-16 μM (Table 3 ). The various AMPs such as LL-37, MUC7, G10KHc, colistin, truncated LL-37 and pleurocidin showed antibiofilm activity [47] [48] [49] [50] [51] [52] . The antimicrobial and antibiofilm actions of NRC-16 merit further study. Thus far, application of AMPs in the clinical setting has been hampered due to various reasons, and most therapeutic peptides are being developed for topical uses only, with the exception of the anionic lipodepsipeptide daptomycin [53] . Moreover, research on AMPs from fish generally focuses on the development of topical application for dermatological disease [18] , and we also showed that NRC-16 peptide interacted with gelatin, which can have a wound-healing application [21] . These results imply that the presence of peptide in the gelatin matrix may inhibit P. aeruginosa biofilm in a wound environment. Other studies also described that topical antimicrobial protection applied in the biofilm colonized the wound surface [54] [55] [56] . 
Hemolytic and Cytotoxicity Activity of Peptides
In the present study, NRC-16 peptide exhibited good activity against antibiotic-resistant bacterial strains, including biofilm cells. However, their cytotoxicity against mammalian cells (human red blood cells (hRBCs), HaCaT and RAW cell 264.7) should be tested. An effective peptide that can be used for human skin disease treatment should be non-cytotoxic and non-hemolytic [57] . The cytotoxicities of NRC-16 and melittin were tested (Figure 2 ), against hRBCs (human red blood cells), HaCaT cells (human skin keratinocytes cells) and RAW264.7 cells (morphologically monocytes and macrophages). The hemolytic activities of the NRC-16 and melittin are entirely different because the NRC-16 is inactive until 150 μM, whereas melittin showed highest hemolytic activity even at 10 μM. Similarly, NRC-16 was not cytotoxic towards HaCaT cells and RAW264.7 cells up to 50 μM, while melittin showed cytotoxicity even at 5 μM. This clearly indicated that NRC-16, unlike melittin, has antimicrobial activity without a high degree of hemolysis. This may reflect an optimal balance of cationicity and hydrophobicity, which are features needed for antimicrobial activity without hemolysis [58, 59] . 
NRC-16 is Non-Selective against Eukaryotic Membranes Using Liposomes
The difference in activity of melittin and NRC-16 on mammalian cells may lie in their difference in membrane affinity. Therefore, we investigated the effects of these peptides on model vesicles composed of zwitterionic phospholipids, including phosphatidylcholine (PC), PC:cholesterol (CH) (2:1, w/w) and PC:sphingomyelin (SM) (2:1, w/w) as these three lipids are the major constituents of most mammalian membranes. We used different methods such as characterization of Trp environment using fluorescence spectroscopy, calcein leakage and circular dichroism (CD).
To evaluate whether Trp residues have a preference for the interfacial region of lipid bilayers [60] [61] [62] , the Trp fluorescence emission can be followed. When Trp residues move from an aqueous environment (polar) to a membrane environment (less polar) the Trp fluorescence emission spectra has a blue shift. Therefore, the peptide fluorescence emission spectra were followed with increasing concentrations of lipid membrane to evaluate if the Trp is inserting in the lipid membrane. The Trp fluorescence blue shift assay indicated that NRC-16 peptide did not bind with PC, PC:CH (2:1, w/w) and PC:SM (2:1, w/w) ( Figure 3) . The calcein leakage (data not shown) and CD data (Figure 4 ) also indicated that NRC-16 had no interaction with all liposomes, which is consistent with its lack of hemolytic activity in erythrocytes [63] [64] [65] [66] . In fact, NRC-16 peptide interacts with negatively charged sodium dodecyl sulfate (SDS) through electrostatic interaction initially experiences accumulation on the bilayer surface [21] . Moreover, NRC-16 peptide adopted an alpha-helical structure in the lipopolysaccharides (LPS) [21] . This implies that NRC-16 interact with the negatively charged surface molecules, such as LPS of Gram-negative bacteria and SDS. However, NRC-16 did not strongly bind with any of the PC, CH and SM liposomes because of its optimum balance of charge/hydrophobicity; a property that prevented the peptide from undergoing electrostatic/hydrophobic interactions with zwitterionic membranes, resulting in low toxicity towards mammalian cells (Figure 2 ). In contrast, melittin showed a strong interaction with all liposomes. Indeed, melittin adopted appreciable secondary structure in the presence of a mammalian mimetic membrane and caused membrane disruption, which could be associated with its cytotoxic activity [67] . 
Experimental Section
Materials
Rink amide 4-methylbenzhydrylamine resin, fluoren-9-ylmethoxycarbonyl (Fmoc) amino acids, and other reagents for peptide synthesis were purchased from Calibochem-Novabiochem (La Jolla, CA, USA). CH from porcine liver, egg yolk l-α-PC and SM were obtained from Avanti Polar Lipids, Co. (Alabaster, AL, USA). Calcein was obtained from Molecular Probes (Eugene, OR, USA). All other reagents were of analytical grade. All buffers were prepared using double distilled water (Millipore Co., Bedford, MA, USA).
Peptides Synthesis
Peptides were synthesized and purified as reported previously [21, 68] . The purity of these peptides was found to be >95%. The concentrations of the peptides were calculated by UV absorption at 280 nm using extinction coefficients determined by ProtParam [69] .
Antibacterial Activity
The antibacterial activity of the peptides against Gram-negative and Gram-positive strains was examined using the microbroth dilution method [68] . Aliquots of bacterial suspensions in mid-logarithmic phase at a concentration of 2 × 10 5 colony forming units (CFU)/mL in culture medium were added to each well, containing peptide solutions diluted with two-fold serial in 10 mM SP buffer (pH 7.2) or PBS ( 
Antifungal Activity
To assess the activity of NRC-16 against various fungal pathogens, fungal spores (C. albicans (KCTC 7270) and CCARM (Culture Collection of Antibiotic-Resistant Microbes) 14001 and T. beigelli (KCTC 7707)) from seven-day-old cultures grown on potato dextrose broth (PDA) plates at 25 °C were collected using 0.08% Triton X-100 [70] . Its surfactant property disperses the spore clumps from the PDA media [71] . Yeast cultures grown overnight were then suspended in PDA media. Spore concentrations were then adjusted to 5 × 10 4 spores/mL in medium composed of half PDA media and half appropriate buffer, after which 80 μL was added to the wells of sterile 96-well flat-bottomed microtiter plates along with 20 μL of peptide or media to give final concentrations of 1-64 μM/mL. After incubating for 24-36 h at 25 °C, the lowest concentration of peptide-inhibiting fungal growth was microscopically determined as the MIC [72] .
In Vitro Activity of the NRC-16 Peptide against Clinical Isolated P. aeruginosa and S. aureus Strains
The antimicrobial activity of each peptide was tested using a broth microdilution assay following the procedure recommended by the NCCLS, with slight modifications [31, 32] . Briefly, bacteria were grown to the stationary phase overnight in MHB at 200 rpm and 37 °C. The cultures were then diluted with fresh MHB to a final concentration of 2 × 10 5 CFU/mL. Next, a 256 μM/mL stock solution of each peptide was prepared in 0.01% acetic acid and 0.2% bovine serum albumin (BSA) in a polypropylene microtube. The peptide solution was then subjected to a series of two-fold dilutions in 0.01% acetic acid and 0.2% BSA until reaching a final concentration of 1-64 μM/mL. Next, 100-μL aliquots of the microbial suspension were dispensed into each well of a 96-well polypropylene microtiter plate (Costar 3790; Corning, NY, USA), after which 10 μL of the peptide solutions were added. After 24 h of incubation at 37 °C, the antibacterial activities of the peptides were assessed based on optical densities (ODs) in each well. Absorbance of the optical densities was recorded at 620 nm using a Versa-Max microplate Elisa Reader (Molecular Devices Co., Sunnyvale, CA, USA). The MIC was expressed as the lowest concentration that inhibited the cell growth. There were three replicates for each test sample. The MBC was determined by streaking a 5 μL aliquot of the microtiter plate reaction mixture onto an MHB agar plate for the three serial dilution wells above and below the determined MIC. 
Biofilm Forming Strains Subjected to Susceptibility Assay with NRC-16, Melittin and Some Conventional Antibiotics
To examine the inhibitory effect of test agents (NRC-16, melittin and antibiotics) on the biofilm growth, the tissue culture plate (TCP) method was employed with a few modifications [73] . Bacterial strains were cultured in a MHB supplemented with 0.2% glucose. Next, each test agent was diluted in 0.01% acetic acid and 0.2% BSA. Individual wells of sterile, polystyrene, 96-well-flat bottom TCPs were filled with 90 μL of P. aeruginosa (1 × 10 6 CFU/mL) cells, after which 10 μL of test agent was added, with the test agent concentration in the range of 512 to 1 μM. For control, no test agents were added in the wells. The cells in performed biofilms were then incubated for 24 h at 37 °C and the wells were carefully washed with PBS to eliminate free-floating bacteria. [48] . MBIC was defined as the lowest concentration that showed 100% inhibition of the formation of the biofilm. Experiments were performed in triplicate and the data was then averaged.
Hemolysis and Cytotoxicity
The hemolytic activity against fresh hRBCs and cytotoxic activity against HaCaT cell (human keratinocyte) and RAW264.7 (macrophage) cells were examined using a previously described method [21, 68] .
Trp Fluorescence Assay
Large unilamellar vesicles (LUVs) were prepared using the freeze-thaw method, respectively [74] . Briefly, dry lipid films were resuspended in 1-2 mL of appropriate buffer by vortexing. LUVs were prepared through eight freeze-thaw cycles under liquid nitrogen and water bath at 50 °C. After preparation of vesicles, suspensions were then extruded 13 times through 0.2 μM polycarbonate membranes, and lipid concentrations were determined by a standard phosphate assay [75] .
To characterize the Trp environment of the peptides, we used fluorescence spectroscopy to examine the binding of the peptides to lipid bilayers. Fluorescence emission spectra of Trp residue in peptides were monitored in the presence of PC, PC:CH (2:1, w/w) and PC:SM (2:1, w/w) as previously described [76] . East peptide was added to 1 mL of 200 μM liposomes, and the peptide:liposome mixture (a molar ratio of 1:100) was allowed to interact at 25 °C for 10 min. The Trp fluorescence measurements were taken using a spectrofluorometer (Perkin-Elmer LS55, Mid Glamorgan, UK) at an excitation wavelength of 280 nm and an emission wavelength ranging from 300 to 400 nm.
Calcein Leakage
Calcein leakage assay was performed to investigate interactions between AMPs and model liposomes [77] . LUVs with entrapped calcein in a suspension containing 100 μM lipid were then incubated for 25 min with various concentrations of melittin or NRC-16 (0.625-10 μΜ). The permeabilizing activity of peptides was assayed by measuring calcein leakage from LUVs with entrapped calcein using a previously described method [68, 76, 78] .
CD Spectroscopy
The CD spectra were recorded on a Jasco 810 spectropolarimeter (Jasco, Tokyo, Japan) equipped with a temperature control unit using a 0.1-cm path-length quartz cell at 25 °C between 190 and 250 nm. The CD spectra were measured for peptide samples (50 μM) that were dissolved in PBS (pH 7.2) containing 1-mM PC, 1-mM PC:CH (2:1, w/w) vesicles or 1-mM PC:SM (2:1, w/w) vesicles. CD data represent the average value from three separate recordings, with four scans per sample. All CD spectra shown have had the corresponding peptide-free solvent baselines subtracted. The results are expressed in terms of molar residue CD.
Conclusions
In summary, peptide NRC-16 displayed antimicrobial activity against a wide range of Gram-negative bacteria, Gram-positive bacteria and fungal strains, including clinically isolated bacterial strains such as P. aeruginosa and S. aureus. This peptide clearly inhibited biofilm formation from P. aeruginosa. Furthermore, unlike melittin, NRC-16 peptide showed no cytotoxicity due to its non-interaction with eukaryotic membranes. NRC-16 may thus prove beneficial in human medicine, and be possibly used for the inhibition of bacterial biofilm infection at wound sites.
